NCT06195618View on ClinicalTrials.gov

Personalized Vaccine for TNBC Immunotherapy

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2028

Conditions
Breast Cancer Female
Interventions
BIOLOGICAL

Peptide (neoantigen) pulsed autologous Dendritic cell

Intradermal vaccination with peptide-pulsed autologous dendritic cells in 200 µL of patient's serum in six doses, one weekly after surgery.

Trial Locations (1)

111321

Facultad de Medicina - Universidad Nacional de Colombia, Bogotá

All Listed Sponsors
collaborator

Fundación Salud de los Andes

OTHER

lead

Universidad Nacional de Colombia

OTHER